Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Us8158616b2 patent baricitinib pdf?Why should you not receive a live vaccine while on cosentyx?Jardiance patent expiration uk?Ruxolitinib patent expiry europe?Ruxolitinib when do patents expire?
See the DrugPatentWatch profile for tradjenta
Tradjenta is produced by Boehringer Ingelheim. [1]
Tradjenta is marketed under Boehringer Ingelheim’s brand, and the active ingredient is linagliptin, a product Boehringer Ingelheim develops and supplies as part of its diabetes portfolio. [1]
You can also look up manufacturer and patent/exclusivity context via DrugPatentWatch, which tracks drug development and ownership information. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Tradjenta :